搜索
Q C Technologies Ord Shs
QCLS添加自选
0.865USD
-0.028-3.13%
交易中 09/23, 14:38（美东）
6.79M总市值
0.03市盈率 TTM
关于 公司
Q C Technologies Ord Shs 简介
公司代码- -
公司名称- -
上市日期- -
CEO- -
员工数量- -
证券类型- -
年结日- -
公司地址- -
城市- -
上市交易所- -
国家- -
邮编- -
电话- -
网址- -
公司代码- -
上市日期- -
CEO- -
Q C Technologies Ord Shs公司高管
名称
名称/职务
职务
持股
持股变动
Ms. Chelsea Voss
Ms. Chelsea Voss
Director
Director
239.90K
--
Mr. Christopher C. Schreiber
Mr. Christopher C. Schreiber
Director
Director
27.19K
+91.94%
Mr. Christopher C. Schreiber
Mr. Christopher C. Schreiber
Director
Director
27.19K
+91.94%
Mr. Stephen Friscia
Mr. Stephen Friscia
Independent Director
Independent Director
25.00K
-8.64%
Mr. Stephen Friscia
Mr. Stephen Friscia
Independent Director
Independent Director
25.00K
-8.64%
Dr. Mitchell Glass, M.D.
Dr. Mitchell Glass, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
12.50K
-8.64%
Dr. Mitchell Glass, M.D.
Dr. Mitchell Glass, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
12.50K
-8.64%
Mr. Bill Joe White
Mr. Bill Joe White
Independent Director
Independent Director
--
--
Mr. Joshua N. (Josh) Silverman
Mr. Joshua N. (Josh) Silverman
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Ian Rhodes
Mr. Ian Rhodes
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Ms. Chelsea Voss
Ms. Chelsea Voss
Director
Director
239.90K
--
Mr. Christopher C. Schreiber
Mr. Christopher C. Schreiber
Director
Director
27.19K
+91.94%
Mr. Christopher C. Schreiber
Mr. Christopher C. Schreiber
Director
Director
27.19K
+91.94%
Mr. Stephen Friscia
Mr. Stephen Friscia
Independent Director
Independent Director
25.00K
-8.64%
Mr. Stephen Friscia
Mr. Stephen Friscia
Independent Director
Independent Director
25.00K
-8.64%
Dr. Mitchell Glass, M.D.
Dr. Mitchell Glass, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
12.50K
-8.64%
常见问题
Q C Technologies Ord Shs的前五大股东是谁？
Q C Technologies Ord Shs 的前五大股东如下：Ms. Chelsea Voss
哪个业务部门对Q C Technologies Ord Shs的收入贡献最大？
在2026Q4，Particle ImmunoFiltration Assay (“PIFA”)业务部门对Q C Technologies Ord Shs的收入贡献最大，创收1.33M，占总收入的84.19%。